All companies
Visit website
VIIT HEALTH
OperatingViiT Health Inc
Technology · AI · Founded 2021
Non-invasive painless glucometer monitors blood sugar levels with top accuracy
Valuation cap ⓘ
$20.0M
As of Jul 2024 · from VIIT HEALTH Future Equity SAFE 2 · a SAFE/note conversion ceiling, not a priced valuation
Total raised
$797,751
Across 3 rounds since 2021
Latest share price
$1.00
Reg CF Offering (2025) offering price
Financials
FY2019–FY2024 · from SEC filings · hover any figure for its source$0
2019
$0
2020
$0
−$60K
2021
$0
−$662K
2022
$0
−$534K
2023
$0
−$347K
2024
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
Income statement
Revenue
$0
$0
$0
$0
$0
$0
Cost of goods sold
$0
$0
$0
$0
$0
$0
Net income
$0
$0
-$60,048
-$662,489
-$533,768
-$346,594
Taxes paid
$0
$0
$0
$695
$450
$850
Balance sheet
Cash
$0
$0
$139,952
$8,670
$13,044
$25,065
Accounts receivable
$0
$0
$0
$0
$0
$0
Total assets
$0
$7,500
$139,952
$8,670
$13,044
$25,065
Short-term debt
$0
$0
$0
$0
$0
$0
Long-term debt
$0
$0
$200,000
$731,208
$1,330,283
$1,688,898
Total liabilities
$0
$0
$200,000
$731,208
$1,330,283
$1,688,898
Other
Headcount
—
4
—
1
—
12
Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didn’t state one. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Post-money = pre-money + amount raised · caps marked$15.0M
Valuation cap
$20.0M
Valuation cap
VIIT Health Future Equity SAFE 1
VIIT HEALTH Future Equity SAFE 2
A dashed amber step is a SAFE/note valuation cap — a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.
Fundraising history
Raised $0 / $618K
Raised $303.1K / $618KInvestors 446Valuation cap $20M
Raised $494.6K / $2M
Reg CF annual-report compliance
Delinquent
Filed 2 of 5 annual reports (FY2021–FY2025)
Missing: 2021, 2023, 2025
607 investors
holder-count proxy
Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.
SEC filings
View all 10 filings on EDGARSource: ManualCIK 0001881570Share price $1.00
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.